Previous studies have demonstrated that TNF-α, interleukin (IL)-6 and IL-8 are important proinflammatory cytokines in the pathogenesis of RA (21–24), and that the inhibition of TNF-α and IL-6 is effective in the treatment of patients with RA (25–27). This evidence concerns the gene CXCL8 and rheumatoid arthritis.